The Actemra drug market is estimated to be valued at USD 4.13 Bn in 2025 and is expected to reach USD 7.41 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032. https://timessquarereporter.com/news/actemra-drug-market-to-witness-growth-owing-to-monoclonal-antibody-innovations